New treatment strategies in amyotrophic lateral sclerosis: solutions or illusions?
Robberecht
W
W
D000690:Amyotrophic Lateral Sclerosis / Q000378:metabolism / Q000628:therapy*; D000975:Antioxidants / Q000627:therapeutic use; D001327:Autoimmune Diseases / Q000378:metabolism; D018691:Excitatory Amino Acid Antagonists; D005609:Free Radicals / Q000633:toxicity; D005971:Glutamates / Q000378:metabolism; D006801:Humans; D009414:Nerve Growth Factors / Q000378:metabolism; D009419:Nerve Tissue Proteins / Q000378:metabolism / Q000627:therapeutic use
D000975:Antioxidants; D018691:Excitatory Amino Acid Antagonists; D005609:Free Radicals; D005971:Glutamates; D009414:Nerve Growth Factors; D009419:Nerve Tissue Proteins